Desentum Oy
PrivateLast Round
VC Round
Apr 27, 2026
Total Funding Raised
$28.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Desentum Oy is a clinical-stage biopharmaceutical company that develops novel allergen immunotherapy products designed to switch the immune system's response to allergens from hypersensitivity to tolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Desentum Oy Comparables
Compare Desentum Oy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Angany | 81% | |
| Aravax | 81% | |
| Mabylon AG | 78% |
Desentum Oy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 27, 2026 | ||||
| Series C | Feb 20, 2024 | ||||
| Series A | Jan 21, 2022 | ||||
| VC Round | Nov 1, 2019 | ||||
| Grant | Oct 29, 2018 | ||||
Crowdfunding | Nov 29, 2017 |
Desentum Oy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascara Ventures | Series A |
| VTT Holding | Series A |
| European Innovation Council Fund | Grant |
| Springvest | VC Round, Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
$21.15M round led by Springvest
- Jul 18, 2025
Grew 33% QoQ from 9 to 12 employees.
Desentum Oy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Desentum Oy's valuation, stock price, and market status.
Is Desentum Oy a public or private company?
Desentum Oy is a private company.
What is the current stock price of Desentum Oy?
Desentum Oy is a private company with no public stock price. No recent secondary market data is available.
How much is Desentum Oy worth (valuation)?
Valuation information for Desentum Oy is not publicly available.
Can I buy Desentum Oy stock?
Desentum Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Desentum Oy's last funding round?
Desentum Oy's most recent funding round was VC Round on April 27, 2026.
Who are the main investors in Desentum Oy?
Key investors in Desentum Oy include Cascara Ventures, Springvest.
Will Desentum Oy IPO soon?
No public IPO plans have been announced for Desentum Oy.
How can I track Desentum Oy secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Desentum Oy's secondary market activity and sign up for updates.